Effectiveness of digital health interventions on antiretroviral therapy adherence among people living with HIV in India: A systematic review with an RCT-only meta-analysis - Takeaways - MDSpire

Effectiveness of digital health interventions on antiretroviral therapy adherence among people living with HIV in India: A systematic review with an RCT-only meta-analysis

  • By

  • Vaibhav Gupta

  • Vishal Deo

  • Barnali Deka

  • Garima Jain

  • Sunny Yadav

  • Sanghamitra Pati

  • June 15, 2026

  • 0 min

Share

  • 1

    Adherence to antiretroviral therapy (ART) among HIV-positive individuals in India remains a significant challenge, with many failing to meet the optimal adherence benchmark.

  • 2

    Digital health interventions, including SMS reminders and electronic adherence monitors, have shown promise in improving ART adherence and reducing viral loads.

  • 3

    A systematic review and meta-analysis was conducted to evaluate the effectiveness of digital health strategies on ART adherence among HIV-positive individuals in India.

  • 4

    Factors such as forgetfulness, stigma, and financial issues contribute to suboptimal ART adherence among the HIV-positive population in India.

  • 5

    The study aims to identify effective digital health technologies and their impact on ART adherence and related treatment outcomes in the Indian HIV population.

Original Source(s)

Effectiveness of digital health interventions on antiretroviral therapy adherence among people living with HIV in India: A systematic review with an RCT-only meta-analysis

  • by Vaibhav Gupta, Vishal Deo, Barnali Deka, Garima Jain, Sunny Yadav, Sanghamitra Pati

  • June 15, 2026

Related Content

Environmental and social determinants of health enhance machine learning models for pneumonia readmission

Porcine xenotransplantation in the clinical era: converging advances and unresolved barriers on the path to clinical translation - a narrative review

Opening the black box: insights into ubiquitin-mediated control of innate antiviral immunity and AI-enhanced therapeutics